期刊
JOURNAL OF CLINICAL LABORATORY ANALYSIS
卷 36, 期 9, 页码 -出版社
WILEY
DOI: 10.1002/jcla.24656
关键词
ALP; bone turnover markers; clinical utility; CTX; metabolic disease; osteocalcin; pediatrics; PINP
资金
- Sichuan Province Science and Technology Support Program [2020YFS0107]
- Chengdu Science and Technology Support Program [2021-YF05-01500-SN]
Bone turnover markers are crucial in pediatric medicine, as they can aid in the diagnosis and prognosis of bone metabolic disorders.
Background Bone turnover markers (BTMs) have been studied for application in clinical medicine. However, BTMs in children are challenging, and few studies explore these BTMs in children. The application of BTMs is complicated mainly due to pre-analytical factors, variable reference intervals of age- and sex-related BTMs for adolescents and children in different regions and laboratories. Therefore, laboratory testing of BTMs is critical for understanding pediatric bone development and metabolism, which provides additional information about bone development and diseases. Methods Literature search was conducted using the MeSH term child combined with the terms that bone turnover markers such as osteocalcin, Procollagen type I N-terminal propeptide, procollagen type I C-terminal propeptide, osteocalcin, N-terminal cross-linked telopeptide, and C-terminal cross-linked telopeptide, Several databases including Web of Science, Google Scholar, and PubMed were searched to obtain the relevant studies. Results BTMs represent the combined effects of skeletal development, growth, and remodeling in children, which can be used in clinical pediatrics to assist in the diagnosis and prognosis of bone metabolic disorders. Conclusion BTMs are clearly helpful for diagnosis and monitoring of bone growth and development as well as bone metabolic disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据